CompareMarketResearchRequest a sample
Home / Healthcare / Vibriosis Treatment Products

Healthcare · Market report

Vibriosis Treatment Products Market Size, Share and Forecast 2026-2036

The global vibriosis treatment products market is worth USD 191 mn in 2026 and is forecast to reach USD 335 mn by 2036, growing at a 5.8% CAGR. China is the largest country market and Antibiotics is the largest by product segment.

USD 191 mnMarket size 2026
USD 335 mnForecast 2036
5.8%CAGR 2026-2036
ChinaLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global vibriosis treatment products market is worth USD 191 mn in 2026 and is forecast to reach USD 335 mn by 2036, growing at a 5.8% CAGR. China is the largest country market and Antibiotics is the largest by product segment.

ScopeVaccines, antibiotics, probiotics and disinfectants used to prevent and treat Vibrio infections in farmed shrimp and fish.
IndustryHealthcare
Value 2025USD 180 mn
Value 2026USD 191 mn
Value 2036USD 335 mn
CAGR 2026-20365.8%
Volume 2026548 million doses
Volume 2036917 million doses
Average price 2026USD 0.35 per dose
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Vibriosis Treatment Products market size and forecast, 2026-2036

Exhibit 1The global vibriosis treatment products market is forecast to grow from USD 191 mn in 2026 to USD 335 mn by 2036, a rise of 76%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 5.8%
Vibriosis Treatment Products market value, 2025 to 2036Market value by year. 2025: USD 180 mn; 2026: USD 191 mn; 2027: USD 202 mn; 2028: USD 214 mn; 2029: USD 226 mn; 2030: USD 239 mn; 2031: USD 253 mn; 2032: USD 268 mn; 2033: USD 283 mn; 2034: USD 300 mn; 2035: USD 317 mn; 2036: USD 335 mn. Compound annual growth rate 2026 to 2036: 5.8%.2025191 mn2026253 mn2031335 mn20365.8% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 191 mn
2027USD 202 mn
2028USD 214 mn
2029USD 226 mn
2030USD 239 mn
2031USD 253 mn
2032USD 268 mn
2033USD 283 mn
2034USD 300 mn
2035USD 317 mn
2036USD 335 mn

Vibriosis Treatment Products market segmentation

By product

Exhibit 2Antibiotics is the largest segment by product, with 46.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Vibriosis Treatment Products market share by product, 2026Share of 2026 revenue by product. Antibiotics: 46.0%; Probiotics and feed additives: 22.0%; Vaccines: 20.0%; Disinfectants: 12.0%.Antibiotics46.0%Probiotics and feed additives22.0%Vaccines20.0%Disinfectants12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Antibiotics46.0%33.4%USD 88 mn2.5%
Vaccines20.0%28.0%USD 38 mn9.4%
Probiotics and feed additives22.0%28.1%USD 42 mn8.4%
Disinfectants12.0%10.5%USD 23 mn4.4%

By species

Exhibit 3Shrimp adds the most revenue by species, growing from USD 99 mn in 2026 to USD 175 mn by 2036Estimated revenue in USD by species, 2026 and 2036 forecast
Vibriosis Treatment Products market by species, 2026 and 2036Revenue by species in 2026 and 2036. Shrimp: USD 99 mn in 2026, USD 175 mn in 2036, change +77%; Finfish: USD 65 mn in 2026, USD 115 mn in 2036, change +77%; Shellfish and others: USD 27 mn in 2026, USD 45 mn in 2036, change +69%.20262036 forecastChangeShrimp+77%99 mn175 mnFinfish+77%65 mn115 mnShellfish and others+69%27 mn45 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Shrimp52.0%52.3%USD 99 mn5.9%
Finfish34.0%34.2%USD 65 mn5.9%
Shellfish and others14.0%13.4%USD 27 mn5.4%

By route

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Feed44.0%42.0%USD 84 mn5.3%
Immersion24.0%22.0%USD 46 mn4.9%
Injection12.0%14.0%USD 23 mn7.4%
Water treatment20.0%22.0%USD 38 mn6.8%

By stage

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hatchery32.0%32.0%USD 61 mn5.8%
Grow-out48.0%46.0%USD 92 mn5.3%
Broodstock20.0%22.0%USD 38 mn6.8%

By channel

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Veterinary suppliers46.0%42.0%USD 88 mn4.8%
Feed mills32.0%32.0%USD 61 mn5.8%
Direct farm sales22.0%26.0%USD 42 mn7.6%

Top 25 countries for vibriosis treatment products by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 96.0%.

Exhibit 4China is the largest country market at USD 31 mn in 2026, and the three largest countries hold 41.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Vibriosis Treatment Products market, ten largest countries in 2026Ten largest countries by 2026 revenue. China: USD 31 mn, 16.0%; Vietnam: USD 25 mn, 13.0%; India: USD 23 mn, 12.0%; Ecuador: USD 19 mn, 10.0%; Thailand: USD 15 mn, 8.0%; Indonesia: USD 15 mn, 8.0%; Norway: USD 9.5 mn, 5.0%; Chile: USD 9.5 mn, 5.0%; Bangladesh: USD 7.6 mn, 4.0%; Brazil: USD 5.7 mn, 3.0%.China31 mn 16.0%Vietnam25 mn 13.0%India23 mn 12.0%Ecuador19 mn 10.0%Thailand15 mn 8.0%Indonesia15 mn 8.0%Norway9.5 mn 5.0%Chile9.5 mn 5.0%Bangladesh7.6 mn 4.0%Brazil5.7 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1ChinaUSD 31 mn16.0%USD 50 mn5.0%
2VietnamUSD 25 mn13.0%USD 47 mn6.5%
3IndiaUSD 23 mn12.0%USD 45 mn7.0%
4EcuadorUSD 19 mn10.0%USD 34 mn6.0%
5ThailandUSD 15 mn8.0%USD 25 mn5.1%
6IndonesiaUSD 15 mn8.0%USD 27 mn6.1%
7NorwayUSD 9.5 mn5.0%USD 15 mn4.5%
8ChileUSD 9.5 mn5.0%USD 15 mn4.5%
9BangladeshUSD 7.6 mn4.0%USD 15 mn7.0%
10BrazilUSD 5.7 mn3.0%USD 10 mn6.2%
11PhilippinesUSD 5.1 mn2.7%USD 9.8 mn6.7%
12South KoreaUSD 3.0 mn1.6%USD 4.1 mn3.1%
13JapanUSD 2.2 mn1.2%USD 3.0 mn3.2%
14MexicoUSD 1.8 mn0.9%USD 3.5 mn6.9%
15CanadaUSD 1.5 mn0.8%USD 2.1 mn3.1%
16TaiwanUSD 1.3 mn0.7%USD 1.8 mn3.1%
17EgyptUSD 1.2 mn0.6%USD 2.3 mn6.8%
18MalaysiaUSD 1.1 mn0.6%USD 2.1 mn6.9%
19PeruUSD 0.97 mn0.5%USD 1.9 mn6.8%
20SingaporeUSD 0.90 mn0.5%USD 1.7 mn6.9%
21HondurasUSD 0.84 mn0.4%USD 1.6 mn6.9%
22Sri LankaUSD 0.78 mn0.4%USD 1.5 mn6.8%
23PolandUSD 0.74 mn0.4%USD 1.4 mn6.8%
24TurkeyUSD 0.71 mn0.4%USD 1.4 mn6.9%
25Saudi ArabiaUSD 0.67 mn0.3%USD 1.3 mn6.7%
Rest of worldUSD 7.7 mn4.0%USD 12 mn4.7%
Exhibit 5India and Vietnam account for 31% of the USD 144 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Vibriosis Treatment Products market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 191 mn. India: +USD 22 mn; Vietnam: +USD 22 mn; China: +USD 19 mn; Ecuador: +USD 15 mn; Indonesia: +USD 12 mn; 20 other countries: +USD 49 mn; Rest of world: +USD 4.4 mn. Market value 2036: USD 335 mn.Market value 2026191 mnIndia+22 mnVietnam+22 mnChina+19 mnEcuador+15 mnIndonesia+12 mn20 other countries+49 mnRest of world+4.4 mnMarket value 2036335 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Zoetis
  • Elanco
  • Merck Animal Health
  • Benchmark Holdings
  • Pharmaq

Group 2: Regional and specialist players

  • Veterquimica
  • Phibro Animal Health
  • Ceva Sante Animale
  • Kemin
  • Alltech
  • Novus International
  • Adisseo
  • Novonesis

Group 3: Emerging and niche players

  • INVE Aquaculture
  • Prilabsa International
  • Blue Aqua International
  • Vaxxinova

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the vibriosis treatment products market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.8% is calculated from the resulting values.

The market is divided by product, by species, by route, by stage, by channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the vibriosis treatment products market?

The global vibriosis treatment products market is estimated at USD 180 mn in 2025 and USD 191 mn in 2026.

How fast will the vibriosis treatment products market grow?

It is forecast to reach USD 335 mn by 2036, a compound annual growth rate of 5.8% from 2026, an increase of USD 144 mn.

Which country is the largest market for vibriosis treatment products?

China is the largest market by revenue at USD 31 mn in 2026, 16.0% of the global total. The three largest countries together hold 41.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 7.0% a year from 2026 to 2036.

Which vibriosis treatment products segment is largest?

In the by product split, Antibiotics is the largest segment with 46.0% of 2026 revenue.

Who are the leading vibriosis treatment products companies?

Global leaders include Zoetis, Elanco, Merck Animal Health, Benchmark Holdings.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Vial Virus Inactivation →

All Healthcare markets →

Request a sample